# Configurations

| UniProt Accession Number   | Reagent Type     | Target Name / Protein Biomarker   | Target Species   | Host Organism   | Isotype   | Clonality   | Vendor          | Catalog Number   | Conjugate   | RRID       | Availability   | Method                 | Tissue Preservation               | Target Tissue   | Tissue State   | Detergent         | Antigen Retrieval Conditions   | Dye Inactivation Conditions   | Recommend   | Agree               | Disagree   | Contributor         | Notes       |
|:---------------------------|:-----------------|:----------------------------------|:-----------------|:----------------|:----------|:------------|:----------------|:-----------------|:------------|:-----------|:---------------|:-----------------------|:----------------------------------|:----------------|:---------------|:------------------|:-------------------------------|:------------------------------|:------------|:--------------------|:-----------|:--------------------|:------------|
| P06332                     | Primary Antibody | CD4                               | Mouse            | Human           | IgG1      | REA604      | Miltenyi Biotec | 130-119-132      | APC-Vio 770 | AB_2733118 | Stock          | Multiplexed 2D Imaging | 1:4 Cytofix/Cytoperm Fixed Frozen | Lymph Node      | NA             | 0.3% Triton-X-100 | NA                             | NA                            | Yes         | 0000-0002-6980-8900 | NA         | 0000-0002-6980-8900 | [1](#notes) |

# Publications



# Additional Notes

<a name="notes"></a>
1. Antibody labels T cells and colocalizes with CD3 but signal is very dim. Use at a concentration of 1:20. This conjugate has not been evaluated for its sensitivity to LiBH4 treatment but is a better alternative than PE-Vio 770.
